Frier Levitt attorneys speak with prosecutors, Boards of Pharmacies, PBM auditors, wholesalers, and the like on a daily basis on behalf of pharmacies nationally. We regularly spot trends and report back to the industry. We are closely monitoring... Read More
The healthcare and life science industries should be aware of the recent increase in False Claims Act (“FCA”) or “whistleblower” cases. In fiscal year 2022, the Department of Justice (“DOJ”) recovered $2.2 billion under the FCA. In 2021,... Read More
Combatting opioid diversion remains a top priority for regulators and enforcement agencies. In that vein, there continues to be enhanced scrutiny on healthcare professionals over opioid prescriptions. As highlighted by recent Department of... Read More
In the wake of the Federal Trade Commission (“FTC”) enforcement action against GoodRx last month, the agency has issued another proposed consent order against virtual mental health platform BetterHelp on a similar basis. Namely, the... Read More
Frier Levitt Partner Guillermo J. Beades was quoted in a Part B News article, “Be Careful About Upcoding; DOJ May Come After it as a False Claim” by Roy Edroso. “It’s very rare for audits to be converted to civil or criminal actions,”... Read More
On February 22, 2023, the U.S. Department of Justice (“DOJ”) issued a corporate Voluntary Self-Disclosure policy (the “Policy”) that applies to all United States Attorney’s Offices (“USAOs”), effective immediately. The articulated goal... Read More
A motion to dismiss that has been pending since last year was recently decided in the matter of U.S. ex rel. Teresa Ross v. Independent Health Association, et al. The decision may very well be a bellwether for future Medicare Advantage (“MA”)... Read More
Having served for nearly a decade as a federal prosecutor with the Department of Justice (“DOJ”), I always understood that whether a violation of the Anti-Kickback Statute (“AKS”) will result in criminal charges versus a civil lawsuit for... Read More
America spends more on prescription drugs than any other country in the world. Although most patients have some form of insurance to help offset the costs of their prescriptions, 28% of Americans currently take a prescription medication that is not... Read More
All members of the health care industry have a legal and ethical duty to deal with the Federal health care programs (e.g., Medicare, Medicaid, and Tricare) with integrity. In keeping with this duty, practitioners are expected to employ measures to... Read More
